Sedana Medical AB (publ) financials
Sedana Medical AB (publ)
549300FQ3NJRI56LCX32 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 178.8M | SEK 153.9M |
| Cost of sales | SEK 52.6M | SEK 44.9M |
| Gross profit | SEK 126.1M | SEK 109.0M |
| Other income | SEK 26.4M | SEK 31.5M |
| Administrative expenses | SEK 51.8M | SEK 47.5M |
| Depreciation & amortisation | SEK 16.1M | SEK 15.5M |
| Operating profit (EBIT) | -SEK 50.8M | -SEK 65.5M |
| Net finance income / (cost) | SEK 40.8M | SEK 6.5M |
| Finance costs | SEK 8.0K | SEK 9.3M |
| Profit before tax | -SEK 9.9M | -SEK 59.0M |
| Income tax expense | SEK 726.0K | SEK 593.0K |
| Profit for the year | -SEK 10.7M | -SEK 59.6M |
| Total comprehensive income | -SEK 12.3M | -SEK 59.2M |
| Per share | ||
| Basic EPS | SEK -0.11 | SEK -0.60 |
| Diluted EPS | SEK -0.11 | SEK -0.60 |
| Free cash flow / share | SEK -0.14 | SEK -0.39 |
| Cash flow statement | ||
| Net cash from operating activities | -SEK 11.8M | -SEK 38.1M |
| Income taxes paid | SEK 718.0K | SEK 564.0K |
| Net cash from investing activities | -SEK 44.7M | -SEK 322.0M |
| Purchase of PP&E (capex) | SEK 2.2M | SEK 515.0K |
| Purchase of intangibles | SEK 172.8M | SEK 168.4M |
| Net cash from financing activities | -SEK 3.6M | -SEK 4.9M |
| Lease liability payments | SEK 3.6M | SEK 4.9M |
| Net change in cash | -SEK 60.0M | -SEK 364.9M |
| Balance sheet | ||
| Total assets | SEK 1.02B | SEK 1.01B |
| Non-current assets | SEK 741.2M | SEK 554.4M |
| Right-of-use assets | SEK 6.3M | SEK 4.9M |
| Intangible assets & goodwill | SEK 26.6M | SEK 0 |
| Current assets | SEK 278.2M | SEK 459.6M |
| Inventories | SEK 45.6M | SEK 43.0M |
| Trade & other receivables | SEK 26.5M | SEK 24.2M |
| Cash & equivalents | SEK 194.0M | SEK 231.2M |
| Total equity | SEK 958.2M | SEK 970.0M |
| Non-current liabilities | SEK 9.4M | SEK 1.0M |
| Lease liabilities (non-current) | SEK 2.6M | SEK 1.0M |
| Current liabilities | SEK 51.6M | SEK 43.0M |
| Lease liabilities (current) | SEK 3.3M | SEK 3.3M |
| Deferred tax liabilities | SEK 6.0K | SEK 7.0K |
| Derived metrics | ||
| Free cash flow | -SEK 14.0M | -SEK 38.6M |
| Operating margin | -28.4% | -42.6% |
| Net margin | -6.0% | -38.7% |
| Return on equity | -1.1% | -6.1% |
| Cash conversion ratio | 1.10× | 0.64× |
| Capex coverage | -5.31× | -73.91× |
| Other reported items | ||
| Additional Paidin Capital | SEK 1.23B | SEK 1.23B |
| Adjustments For Decrease Increase In Inventories | SEK 2.6M | -SEK 6.7M |
| Adjustments For Decrease Increase In Other Operating Receivables | SEK 2.2M | -SEK 6.3M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | SEK 23.2M | SEK 24.9M |
| Adjustments For Increase Decrease In Other Liabilities | SEK 166.0K | -SEK 7.9M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -SEK 5.6M | SEK 8.9M |
| Cash Flows From Used In Operations Before Changes In Working Capital | -SEK 16.8M | -SEK 17.1M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | SEK 25.0M | SEK 0 |
| Comprehensive Income Attributable To Owners of Parent | -SEK 12.3M | -SEK 59.2M |
| Copyrights Patents and Other Industrial Property Rights Service and Operating Rights | SEK 3.6M | SEK 3.3M |
| Current Accruals and Current Deferred Income Including Current Contract Liabilities | SEK 28.6M | SEK 24.8M |
| Current Prepayments and Current Accrued Income Other Than Current Contract Assets | SEK 5.9M | SEK 4.7M |
| Current Tax Assets Current | SEK 2.4M | SEK 739.0K |
| Current Tax Liabilities Current | SEK 3.1M | SEK 1.3M |
| Deferred Tax Assets | SEK 22.0K | SEK 31.0K |
| Depreciation Expense | SEK 5.5M | SEK 7.1M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 22.8M | -SEK 11.7M |
| Equity and Liabilities | SEK 1.02B | SEK 1.01B |
| Finance Income | SEK 40.8M | SEK 15.9M |
| Increase Decrease Through Sharebased Payment Transactions | SEK 498.0K | — |
| Increase Decrease Through Transactions With Owners | SEK 498.0K | — |
| Interest Paid Classified As Operating Activities | SEK 178.0K | SEK 215.0K |
| Interest Received Classified As Operating Activities | SEK 16.5M | SEK 15.2M |
| Issued Capital | SEK 2.5M | SEK 2.5M |
| Liabilities | SEK 61.2M | SEK 44.1M |
| Machinery | SEK 588.0K | SEK 864.0K |
| Noncurrent Provisions | SEK 162.0K | SEK 7.0K |
| Other Adjustments For Noncash Items | SEK 886.0K | SEK 208.0K |
| Other Comprehensive Income | -SEK 1.6M | SEK 451.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -SEK 1.6M | SEK 451.0K |
| Other Current Financial Assets | SEK 0 | SEK 150.6M |
| Other Current Liabilities | SEK 10.6M | SEK 8.5M |
| Other Current Receivables | SEK 3.9M | SEK 5.2M |
| Other Expense By Function | SEK 26.4M | SEK 30.5M |
| Other Noncurrent Financial Liabilities | SEK 6.8M | SEK 0 |
| Other Noncurrent Receivables | SEK 47.0K | SEK 46.0K |
| Research and Development Expense | SEK 20.3M | SEK 20.8M |
| Reserve of Exchange Differences On Translation | -SEK 3.8M | -SEK 2.2M |
| Retained Earnings | -SEK 267.4M | -SEK 256.7M |
| Selling Expense | SEK 104.8M | SEK 107.2M |
| Trade and Other Current Payables To Trade Suppliers | SEK 6.0M | SEK 5.2M |
Every line item above is a fact tagged in Sedana Medical AB (publ)'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.